Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Vita Life Sciences Limited ( (AU:VLS) ) has shared an update.
Vita Life Sciences Limited has announced an update on its ongoing on-market buy-back program. As of September 18, 2025, the company has bought back a total of 202,701 ordinary fully paid securities, including 6,960 securities purchased on the previous day. This buy-back initiative is part of the company’s strategy to manage its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (AU:VLS) stock is a Buy with a A$2.50 price target. To see the full list of analyst forecasts on Vita Life Sciences Limited stock, see the AU:VLS Stock Forecast page.
More about Vita Life Sciences Limited
Vita Life Sciences Limited operates in the health and wellness industry, focusing on the development and distribution of nutritional and healthcare products. The company is known for its range of vitamins, supplements, and other health-related products, catering to a diverse market seeking wellness solutions.
Average Trading Volume: 13,088
Technical Sentiment Signal: Buy
Current Market Cap: A$133.1M
See more insights into VLS stock on TipRanks’ Stock Analysis page.